Natriumhydrogencarbonat Fresenius (Sodium Hydrogen Carbonate)

Sodium hydrogen carbonate, the active ingredient in Natriumhydrogencarbonat Fresenius, is an electrolyte solution presented as a sterile solution for injection for intravenous use. It is employed to correct metabolic acidosis and to support resuscitation efforts in cardiac arrest and certain drug overdoses. GNH USA supplies Natriumhydrogencarbonat Fresenius as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natriumhydrogencarbonat Fresenius is used in clinical situations that require rapid correction of systemic acidity or alkalinization of bodily fluids. - Metabolic acidosis: restores normal pH by providing bicarbonate ions. - Cardiac arrest (resuscitation): assists in restoring circulatory function during emergency treatment. - Tricyclic antidepressant overdose: facilitates urinary alkalinization to enhance drug elimination. - Urinary alkalinization: adjusts urine pH for specific renal conditions or toxin clearance.

Administration of Natriumhydrogencarbonat Fresenius may be associated with several adverse reactions.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Mild hypernatremia: slight elevation of serum sodium levels. - Metabolic alkalosis: over‑correction of pH in susceptible patients. - Hypokalemia: reduced serum potassium due to intracellular shift.

Serious or Rare Side Effects: - Severe hypernatremia: marked increase in sodium causing neurologic symptoms. - Severe metabolic alkalosis: significant pH elevation leading to respiratory depression. - Pulmonary edema: fluid overload in patients with compromised cardiac function. - Anaphylaxis: rare hypersensitivity reaction requiring immediate intervention.

Prior to administration, clinicians should evaluate patient-specific factors and monitor relevant parameters. - Renal impairment: monitor serum electrolytes and acid‑base status closely. - Cardiac disease: watch for fluid overload and electrolyte shifts. - Pregnancy: use only when the potential benefit justifies the potential risk to the fetus. - Concomitant alkalinizing agents: avoid excessive alkalosis by adjusting doses. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Sodium hydrogen carbonate can interact with other agents that affect electrolyte balance or acid‑base status.

Major Interactions (Avoid): - Calcium carbonate: may precipitate, reducing efficacy of both agents. - Hypertonic saline combined with sodium bicarbonate: increases risk of severe hypernatremia.

Moderate Interactions (Monitor Closely): - Loop diuretics: may exacerbate potassium loss. - ACE inhibitors: can alter renal handling of sodium and bicarbonate. - Insulin therapy: may cause rapid intracellular potassium shifts.